Method spots early signs of infection after breast cancer reconstruction
In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies. Many of those women opt to… read more.
In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies. Many of those women opt to… read more.
Pharmaceutical products are essential for health, and they play and will continue to play a key role in disease prevention and treatment. However, they are exerting a major… read more.
Pfizer Inc. announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating Braftovi (encorafenib) in combination with cetuximab (Erbitux) and FOLFIRI (fluorouracil,… read more.
HRT via skin is best treatment for low bone density in women whose periods have stopped due to anorexia or exercise, says study. Hormone replacement therapy applied via… read more.
New consumer survey findings from the American Heart Association show that nearly six in every ten American adults still incorrectly believe only those with special training should perform… read more.
Zevra Therapeutics announced the presentation of four posters highlighting positive new data on Miplyffa (arimoclomol) for the treatment of Niemann-Pick Disease Type C (NPC) at the 22nd Annual… read more.
How to reduce suffering in children with advanced cancer remains an ongoing but urgent question. A Mass General Brigham-led study examined whether systematically surveying children with advanced cancer… read more.
As Washington debates how to rein in soaring prescription drug prices, including proposals that would tie U.S. prices to those paid abroad, a new study led by researchers… read more.
Alfresa Pharma released Neffy 1 mg and Neffy 2 mg (adrenaline, epinephrine), which are nasal sprays used as emergency supportive therapy to suppress anaphylaxis, to the Japanese market…. read more.
Addressing a growing demand for graduate training in evaluating medication safety, effectiveness and outcomes in real-world clinical settings, the UH College of Pharmacy is expanding its offerings within the Pharmaceutical… read more.
GSK announced that China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab) as add-on maintenance treatment of adult patients with inadequately controlled COPD characterised by raised blood… read more.
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.